Jennifer Sy serves as Executive at AEON Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Jennifer Sy has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 31, 2024 involved receiving (via award) 18,010 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 31, 2024 | AEON | $0 | Award | 18,010 | $N/A | Discretionary |
Jennifer Sy currently holds 18,010 shares of AEON Biopharma, Inc. (AEON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Sy has been a net neutral trader of AEON stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Sy's most recent insider trade was on Aug 31, 2024, when they sold 18,010 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted